Atea Pharmaceuticals, Inc. Share Price
NASDAQ: AVIR | Small CapAtea Pharmaceuticals, Inc. Stock Performance
Open $5.08 | Prev. Close $5.26 | Circuit Range N/A |
Day Range $5.03 - $5.11 | Year Range $2.80 - $6.43 | Volume 6,682 |
Average Traded $5.05 |
Atea Pharmaceuticals, Inc. Share Price Today
As of 11 August 2026, Atea Pharmaceuticals, Inc.'s share price is $5.01. The stock opened at $5.08, compared to its previous close of $5.26. During today's trading session, Atea Pharmaceuticals, Inc.'s share price traded between $5.03 and $5.11, with an average price of $5.07. Over the past 52 weeks, the stock has recorded a high of $6.43 and a low of $2.80. In terms of performance, Atea Pharmaceuticals, Inc.'s share price has risen by 6.82% over the last six months and is up 48.89% on a year-on-year basis.
Atea Pharmaceuticals, Inc. Share Price Chart
Atea Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $408.29M | PE Ratio (TTM) -2.58 | Dividend Yield N/A |
EPS (TTM) $-1.94 | Revenue (TTM) $351.37M | Return On Equity (TTM) -57.49% |
Profit Margin -45.07% | Debt to Equity 0.14 | Quarterly Earnings Growth YoY -34.98% |
Atea Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Atea Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Atea Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.70 | $5.27 | +12.25% |
Jul 2026 | $4.69 | $4.70 | +0.97% |
Jun 2026 | $4.55 | $4.65 | -0.11% |
May 2026 | $5.41 | $4.66 | -15.59% |
Apr 2026 | $5.43 | $5.51 | +2.60% |
Mar 2026 | $4.71 | $5.38 | +14.61% |
Feb 2026 | $4.18 | $4.69 | +10.61% |
Jan 2026 | $3.52 | $4.24 | +18.27% |
Dec 2025 | $3.05 | $3.58 | +16.02% |
Nov 2025 | $3.21 | $3.09 | -4.63% |
Oct 2025 | $2.91 | $3.24 | +11.72% |
Sep 2025 | $3.36 | $2.90 | -13.82% |
AVIR Share Price FAQs
What is Atea Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Atea Pharmaceuticals, Inc. stock?
What is AVIR's market capitalisation today?
What is AVIR's net income for the last quarter?
What is the 5 year returns of AVIR?
What is the high & low stock price of AVIR today?
Can I buy AVIR shares in India?